Cargando…
Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
The elimination of both cellular and tissue latent reservoirs is a challenge toward a successful HIV cure. “Shock and Kill” are among the therapeutic strategies that have been more extensively studied to target these reservoirs. These strategies are aimed toward the reactivation of the latent reserv...
Autores principales: | Macedo, Amanda B., Novis, Camille L., Bosque, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804373/ https://www.ncbi.nlm.nih.gov/pubmed/31681325 http://dx.doi.org/10.3389/fimmu.2019.02450 |
Ejemplares similares
-
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020) -
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020) -
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023) -
The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like
por: Darcis, Gilles, et al.
Publicado: (2019) -
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
por: Kumar, Sudeep, et al.
Publicado: (2019)